Dexcel Pharma Technologies Ltd. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-02-25 08:32 am Sale | 2020-02-21 | 13G | Intec Pharma Ltd NTEC | Dexcel Pharma Technologies Ltd. | 26,465 4.070% | -26,471 (-50.01%) | Filing |